Konstanti Koutelos
Internal Medicine · Brooklyn, NYNPI 1467545269
Payments from drug & device makers
Across 217 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$503
- AstraZeneca$414
- GSK$255
- Amarin Pharma, Inc.$251
- Johnson & Johnson$213
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,262100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,241 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $503 |
| AstraZeneca | 21 | $414 |
| GSK | 12 | $255 |
| Amarin Pharma, Inc. | 12 | $251 |
| Johnson & Johnson | 11 | $213 |
| E.r. Squibb & Sons, L.L.C. | 9 | $205 |
| Novo Nordisk | 10 | $179 |
| Amgen | 7 | $157 |
| Pfizer | 6 | $101 |
| Kowa Pharmaceuticals America, Inc. | 6 | $92 |
| Merck | 4 | $81 |
| Mylan Specialty L.p. | 2 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $43 |
| Nestle Healthcare Nutrition Inc. | 2 | $42 |
| Vivus LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Novartis | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $30 |
| Forte Bio-pharma LLC | 2 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Avanir Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
| Vistapharm, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
How this compares
$4,262 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 79 | $57,428 |
| Xtampza ErOxycodone Myristate | 94 | $48,201 |
| Oxycodone Hcl | 702 | $26,884 |
| Morphine Sulfate ErMorphine Sulfate | 436 | $12,106 |
| Lidocaine | 23 | $3,520 |
| Hydromorphone Hcl | 77 | $3,442 |
| Ondansetron Hcl | 12 | $2,626 |
| Naproxen | 28 | $2,215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $2,086 |
| Gabapentin | 152 | $2,029 |
| Pregabalin | 30 | $1,529 |
| Cyclobenzaprine Hcl | 84 | $1,043 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 11 | $921 |
| Naloxone Hcl | 12 | $919 |
| Ibuprofen | 142 | $917 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $37 | $48,20194 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.